ProterixBio (formerly known as BioScale) is a company that develops proprietary blood-based biomarker tests to transform the management of chronic respiratory diseases. It provides chronic care platforms to improve patient outcomes, starting with pulmonary diseases.
Type | Private | |
Founded | 2002 | |
HQ | Billerica, MA, US | Map |
Website | proterixbio.com |
Employees (est.) (Jul 2022) | 19 | |
Cybersecurity rating | A | More |
Founding Date | 2002 |
ProterixBio total Funding | $90.2 m |
ProterixBio latest funding size | $18.8 m |
Time since last funding | 9 years ago |
ProterixBio investors | New York Angels, New Science Ventures, Morningside Group, MF Capital, Blackfin Technology, F2 Ventures, WFD Ventures |
When was ProterixBio founded?
ProterixBio was founded in 2002.
Who are ProterixBio key executives?
ProterixBio's key executives are Grace Colón, Brett P. Masters and Charles L. Popkin.
How many employees does ProterixBio have?
ProterixBio has 19 employees.
Who are ProterixBio competitors?
Competitors of ProterixBio include MiCo BioMed, Humasis and DiaSys Diagnostic Systems.
Where is ProterixBio headquarters?
ProterixBio headquarters is located at 1 Fortune Dr, Billerica.
Where are ProterixBio offices?
ProterixBio has an office in Billerica.
How many offices does ProterixBio have?
ProterixBio has 1 office.
Receive alerts for 300+ data fields across thousands of companies